Future Innovation and Technology
Apollo is committed to the continued innovation of the field of flexible surgery, and we actively seek new product opportunities in this ever growing field. We have a robust rapid prototyping and pilot production capacity and strong clinical relationships to accelerate innovation.
Future product development activities:
The SuMO™ Tissue Access and Resection System
Gastrointestinal cancer has a devastating impact on the lives of patients and is the second most common cause of cancer death in the United States. Once a suspicious lesion is identified during routine colonoscopy, physicians have been limited in their ability to treat patients endoscopically. Patients with large flat lesions are typically referred for a surgically invasive procedure which can be comprised of morbidity and digestive complications. The SuMO Tissue Access and Resection System is a highly innovative balloon technology and tissue cutting device that significantly extends the range of lesion sizes to be treated endoscopically.
If you have any further questions, please contact us directly at 1-877-ENDO-130.